PATENT CLAIM ANALYSIS

Application Number: 15973281
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["514", "04400A"]

Abstract:
The present disclosure relates to compositions and methods for treating or preventing a fibrotic disorder or disease.

Claim (Index 18):
The method according to  claim 1 , wherein the fibrotic disease is selected from pulmonary fibrosis, idiopathic pulmonary fibrosis, cystic fibrosis, liver fibrosis, cardiac fibrosis, endomyocardial fibrosis, atrial fibrosis, mediastinal fibrosis, myelofibrosis, retroperitoneal fibrosis, chronic kidney disease, nephrogenic systemic fibrosis, Chron's disease, hypertrophic scarring, keloid, scleroderma, organ transplant-associated fibrosis, or ischemia-associated fibrosis.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 93.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14616690', '15397351', '15319254', '15022663', '15318553']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7652571364980496
- 35 USC 102 Novelty (BERT): 0.6302717284687054
- Combined Prediction Score: 0.7517585956951152
- Mean Citation Score: 321.409978
- Max Citation Score: 664.3534
- Similarity Product: 512.8894671039939

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test